ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Major New Grant Programs Approved In Carcinogenesis, Chemoprevention

May 9, 1980

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

Compromise on 6,000 Grants Would Make NCI Payline Around 163-164: Natcher Committee Close to Markup

June 28, 1985

DCT Advisors Reject MRS Concept, Approve RDOG Expansion

November 30, 1990

ACS Plans To Review Prostate Cancer Screening Guideline

March 20, 2009

In Brief: Cancer Program Get Shot In Arm With Override Of Appropriations Vet; Carter To Leave NCI

February 6, 1976